Skip to main content

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In What does "Remember Me" do?

Don't Know Your Password?
Help

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In

Don't Know Your Password?

Zacks

more

HTG Molecular Diagnostics, Inc. (HTGM)

(Delayed Data from NSDQ)

$2.59 USD

+0.10 (4.02%)

Updated May 3, 2019 04:00 PM ET

After-Market: $2.58 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	23.68%
2	Buy	17.55%
3	Hold	9.21%
4	Sell	4.93%
5	Strong Sell	2.36%
S&P	500	10.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

NA

View All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

HTG Molecular Diagnostics, Inc. [HTGM]

Reports for Purchase

Showing records 1 - 20 ( 90 total )

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 1

04/19/2023

Pages: 6

Three Milestones Achieved on the Drug Discovery Platform; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 12.50

Research Provided by a Third Party

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 2

04/03/2023

Pages: 6

Full-Year 2022 Financial Results Reported; Reiterate Buy; Lowering PT to $6

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 12.50

Research Provided by a Third Party

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 3

01/10/2023

Pages: 5

Solid Progress in Drug Discovery Business; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 5.00

Research Provided by a Third Party

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 4

01/09/2023

Pages: 5

Preliminary 2022 Financial Results Reported; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 5.00

Research Provided by a Third Party

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 5

12/29/2022

Pages: 5

EdgeSeq RNA Profiling Highlighted; Reverse Stock Split Effected; Financing Completed; Reiterate Buy and Institute $15 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 5.00

Research Provided by a Third Party

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 6

11/11/2022

Pages: 5

3Q22 Financial Results Reported; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 5.00

Research Provided by a Third Party

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 7

08/15/2022

Pages: 6

2Q22 Financial Results Reported; Reiterate Buy; Modulating PT to $2

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 12.50

Research Provided by a Third Party

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 8

06/30/2022

Pages: 6

HTG Transcriptome Panel Highlighted in Customer Publication; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 12.50

Research Provided by a Third Party

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 9

05/16/2022

Pages: 6

1Q22 Financial Results Reported; Reiterate Buy; Modulating PT to $3

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 12.50

Research Provided by a Third Party

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 10

04/07/2022

Pages: 5

Harmonization of miRNA and mRNA Profiling; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 5.00

Research Provided by a Third Party

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 11

03/30/2022

Pages: 6

2021 Financial Results Reported; Reiterate Buy; Reducing PT to $4

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 12.50

Research Provided by a Third Party

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 12

01/11/2022

Pages: 6

Preliminary Full Year 2021 Results Reported; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 12.50

Research Provided by a Third Party

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 13

12/23/2021

Pages: 5

Transcriptome Panel Sample Types Expanded With Sequencer Flexibility; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 5.00

Research Provided by a Third Party

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 14

12/10/2021

Pages: 6

Sales Milestone Achieved for Transcriptome Panel; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 12.50

Research Provided by a Third Party

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 15

11/11/2021

Pages: 6

3Q21 Financial Results Reported; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 12.50

Research Provided by a Third Party

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 16

09/28/2021

Pages: 10

ValuEngine Detailed Valuation Report for HTGM

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 17

08/13/2021

Pages: 6

Modest Top-Line Miss, Bottom-Line Beat in 2Q21; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 25.00

Research Provided by a Third Party

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 18

07/21/2021

Pages: 7

New Drug Discovery Business Unit Established; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 25.00

Research Provided by a Third Party

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 19

06/23/2021

Pages: 6

First Commercial Orders Inked for Transcriptome Panel; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 25.00

Research Provided by a Third Party

Company: HTG Molecular Diagnostics, Inc.

Industry: Medical - Instruments

Record: 20

06/15/2021

Pages: 5

Transcriptome Panel Design Lock; Three Collaborations Signed; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 10.00

Research Provided by a Third Party

previous
1
2
3
4
5
next

// eof